Veterinary Molecular Diagnostic Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Product (Instruments, Kit and Reagents, Software and Services), By Application (Infectious Diseases, Genetics, Other), By Technology (PCR, Microarray, DNA Sequencing), By Region and Competition, 2019-2029F
Global Veterinary Molecular Diagnostic Market was valued at USD 0.48 billion in 2023 and is anticipated t%li%project robust growth in the forecast period with a CAGR of 8.65% through 2029. The Global Veterinary Molecular Diagnostics Market is a dynamic sector poised for substantial growth, driven by the increasing demand for precise and rapid diagnostic solutions in animal healthcare. This market encompasses a wide array of molecular diagnostic techniques tailored specifically for veterinary applications, including PCR (Polymerase Chain Reaction), microarrays, sequencing, and other advanced technologies. Key factors fueling market expansion include rising incidences of infectious diseases among animals, the growing prevalence of zoonotic diseases, and the escalating need for early disease detection t%li%ensure optimal animal health and productivity. The emergence of novel pathogens and the constant threat of disease outbreaks underline the importance of robust molecular diagnostic tools in veterinary medicine.
Furthermore, technological advancements such as point-of-care testing and the development of portable diagnostic devices are enhancing accessibility and efficiency in veterinary diagnostics, particularly in remote or resource-limited settings. The market is characterized by a competitive landscape with key players investing in research and development t%li%introduce innovative diagnostic solutions and broaden their product portfolios. Strategic collaborations, mergers, and acquisitions are prevalent strategies among market participants t%li%strengthen their market presence and expand their geographic reach. Regulatory initiatives aimed at standardizing veterinary diagnostics and ensuring product efficacy and safety are als%li%shaping the market landscape. As the global awareness of animal health and welfare continues t%li%rise, coupled with the increasing adoption of pets and livestock for companionship, food production, and other purposes, the veterinary molecular diagnostics market is anticipated t%li%witness sustained growth in the coming years.
Key Market Drivers
Rising Incidences of Infectious Diseases
The rising incidences of infectious diseases among animals have emerged as a significant driver fueling the growth of the Global Veterinary Molecular Diagnostics Market. Across the spectrum of animal populations, including pets, livestock, and wildlife, there has been a notable increase in the prevalence of infectious agents. Pathogens such as bacteria, viruses, fungi, and parasites pose substantial threats t%li%animal health, welfare, and productivity. Factors such as globalization, climate change, intensified livestock production systems, and changes in land use have contributed t%li%the spread and emergence of infectious diseases in animal populations.
Veterinary molecular diagnostics play a pivotal role in addressing this challenge by providing rapid and accurate identification of pathogens. Techniques such as Polymerase Chain Reaction (PCR), nucleic acid sequencing, and microarray analysis enable veterinarians t%li%detect and characterize infectious agents with high sensitivity and specificity. This capability is particularly crucial in the early diagnosis of emerging or novel pathogens for which traditional diagnostic methods may be inadequate or time-consuming. Furthermore, the ability t%li%swiftly identify infectious diseases facilitates prompt implementation of control measures, including quarantine, treatment, and vaccination programs. By containing outbreaks at their inception, molecular diagnostics help prevent the spread of diseases within animal populations and minimize their impact on animal health and productivity. Early detection enables veterinarians t%li%provide targeted treatment strategies, reducing the risk of antimicrobial resistance and improving treatment outcomes.
The demand for veterinary molecular diagnostics is further amplified by the economic consequences associated with infectious disease outbreaks. Disease outbreaks can result in significant losses for the livestock industry due t%li%decreased production, trade restrictions, and increased veterinary and healthcare costs. Timely and accurate diagnosis facilitated by molecular techniques helps mitigate these economic impacts by enabling swift intervention and control measures.
Technological Advancements
Technological advancements have been instrumental in propelling the growth of the Global Veterinary Molecular Diagnostics Market, revolutionizing the landscape of veterinary diagnostics and driving innovation in testing methodologies. These advancements have led t%li%the development of more sophisticated and efficient diagnostic tools, enabling veterinarians t%li%diagnose diseases with greater accuracy, speed, and convenience. One of the key technological advancements driving the veterinary molecular diagnostics market is the advent of Polymerase Chain Reaction (PCR) technology. PCR allows for the amplification of DNA or RNA sequences from a small sample, making it possible t%li%detect even trace amounts of pathogens in clinical specimens. This technique has become a cornerstone of veterinary diagnostics, enabling rapid and sensitive detection of infectious agents such as bacteria, viruses, and parasites.
In addition t%li%PCR, next-generation sequencing (NGS) technologies have revolutionized the field of molecular diagnostics by enabling high-throughput sequencing of entire genomes or targeted gene panels. NGS technologies offer unprecedented insights int%li%the genetic diversity of pathogens, facilitating the identification of emerging strains and the characterization of antimicrobial resistance genes. This information is invaluable for guiding treatment decisions and implementing effective control measures. Furthermore, microarray technology has emerged as a powerful tool for multiplexed detection of pathogens, allowing for the simultaneous analysis of multiple targets in a single assay. Microarrays offer high throughput and versatility, making them well-suited for screening large numbers of samples for infectious agents or genetic markers of disease.
The development of point-of-care testing (POCT) devices and portable diagnostic instruments has als%li%been a significant technological advancement in veterinary molecular diagnostics. These compact and user-friendly devices enable rapid on-site testing in diverse settings, including veterinary clinics, farms, and field research stations. POCT devices facilitate real-time decision-making and prompt initiation of treatment, improving patient outcomes and reducing the spread of infectious diseases.
Key Market Challenges
Cost Constraints
One of the primary challenges facing the Global Veterinary Molecular Diagnostics Market is the high cost associated with molecular diagnostic tests. The initial investment in equipment, reagents, and skilled personnel required t%li%perform molecular assays can be prohibitive for many veterinary clinics, particularly those in resource-limited settings or smaller practices. The cost of molecular tests themselves may be perceived as a barrier by pet owners or livestock producers, especially for routine screening or surveillance purposes. Addressing cost constraints through technological innovations, economies of scale, and strategic pricing strategies is essential t%li%enhance accessibility and affordability of molecular diagnostics in veterinary medicine.
Sample Quality and Handling
The quality of the sample plays a crucial role in the accuracy and reliability of molecular diagnostic tests. However, obtaining high-quality samples from animals can be challenging due t%li%various factors such as sample collection techniques, sample stability during transportation, and the presence of inhibitors that may interfere with molecular assays. Inadequate sample quality or improper handling procedures can lead t%li%false-negative or false-positive results, compromising the diagnostic accuracy of molecular tests. Addressing sample quality and handling challenges requires standardized protocols for sample collection, storage, and transportation, as well as the development of robust quality control measures t%li%assess sample integrity before testing.
Key Market Trends
Increasing Companion Animal Ownership
Increasing companion animal ownership has emerged as a significant driver fueling the growth of the Global Veterinary Molecular Diagnostics Market. The trend of pet ownership has been steadily rising worldwide, driven by factors such as urbanization, changing lifestyles, and growing awareness of the benefits of pet companionship. As more people welcome pets int%li%their homes, the demand for veterinary services, including diagnostic testing, has surged. Companion animals, including dogs, cats, and exotic pets, are valued members of the family, and pet owners are increasingly invested in ensuring their health and well-being. Molecular diagnostics play a crucial role in the diagnosis and management of various diseases and conditions in companion animals, offering greater accuracy, sensitivity, and efficiency compared t%li%traditional diagnostic methods.
One of the key drivers of demand for veterinary molecular diagnostics among pet owners is the desire for early disease detection and preventive care. Pet owners are proactive in seeking regular veterinary check-ups and screening tests for their pets t%li%identify potential health issues before they become symptomatic. Molecular diagnostic tests, such as PCR assays and genetic screening panels, enable veterinarians t%li%detect infectious diseases, genetic disorders, and predispositions t%li%certain conditions at earlier stages, allowing for timely intervention and treatment. The human-animal bond has strengthened in recent years, with pets playing increasingly integral roles in the lives of their owners. Pet owners are more willing t%li%invest in advanced veterinary care, including molecular diagnostics, t%li%ensure the health and longevity of their beloved companions. This emotional attachment t%li%pets drives demand for cutting-edge diagnostic technologies that offer greater diagnostic accuracy and treatment options.
Advancements in veterinary medicine, including personalized medicine and targeted therapies, have further fueled the demand for molecular diagnostics in companion animal healthcare. Molecular diagnostic tests provide valuable information about an individual animal's genetic makeup, enabling veterinarians t%li%tailor treatment plans t%li%the specific needs of each patient.
Focus on Food Safety and Animal Welfare
The focus on food safety and animal welfare has become increasingly prominent in recent years, driving the growth of the Global Veterinary Molecular Diagnostics Market. As consumers become more conscientious about the origin and quality of the food they consume, there is growing demand for rigorous safety standards and transparent supply chains in the food industry. In response, stakeholders across the food production chain, including producers, regulators, and consumers, are prioritizing measures t%li%ensure the safety and welfare of animals raised for food production. Veterinary molecular diagnostics play a critical role in enhancing food safety by enabling the rapid and accurate detection of pathogens in livestock and poultry populations. Infectious agents such as Salmonella, Campylobacter, and Escherichia coli pose significant risks t%li%human health if present in food products. Molecular diagnostic techniques, such as Polymerase Chain Reaction (PCR) and nucleic acid sequencing, offer high sensitivity and specificity in detecting these pathogens, allowing for timely intervention t%li%prevent foodborne illness outbreaks.
Furthermore, molecular diagnostics contribute t%li%animal welfare by facilitating early disease detection and monitoring in livestock populations. Diseases such as bovine respiratory disease, porcine reproductive and respiratory syndrome, and avian influenza can have detrimental effects on animal health and welfare, as well as on productivity in food animal production systems. By identifying infected animals and implementing appropriate control measures, molecular diagnostics help minimize the spread of diseases within herds and flocks, reducing suffering and improving overall welfare. The adoption of molecular diagnostics in veterinary medicine als%li%supports sustainable agricultural practices by promoting responsible antimicrobial use and reducing the need for prophylactic treatments. By accurately diagnosing diseases and identifying the causative agents, veterinarians can prescribe targeted therapies and interventions, minimizing the use of antibiotics and other antimicrobial agents. This approach helps mitigate the risk of antimicrobial resistance and supports the long-term viability of food production systems.
Segmental Insights
Product Insights
Based on the product, kit and reagents segment emerged as the dominant segment in the global Veterinary Molecular Diagnostic market in 2023. the kit and reagents segment benefits from the widespread adoption of molecular diagnostic techniques such as Polymerase Chain Reaction (PCR), which relies heavily on specific kits and reagents for amplification and detection of nucleic acids. These kits and reagents are essential components of molecular assays, enabling veterinarians t%li%perform a wide range of tests for the diagnosis of infectious diseases, genetic disorders, and other conditions in animals. Furthermore, advancements in kit and reagent technologies, such as the development of multiplex assays and ready-to-use PCR kits, have facilitated the adoption of molecular diagnostics in veterinary medicine. These innovations enhance the efficiency, accuracy, and convenience of testing procedures, further driving the growth of the kit and reagents segment.
Application Insights
Based on the application, infectious diseases segment emerged as the dominant segment in the global veterinary molecular diagnostic market in 2023. Infectious diseases pose significant threats t%li%animal health, welfare, and productivity, making their accurate and timely diagnosis a top priority for veterinarians and livestock producers. Molecular diagnostic techniques offer unparalleled sensitivity and specificity in detecting a wide range of pathogens, including bacteria, viruses, fungi, and parasites, facilitating rapid identification and control of infectious disease outbreaks. As the global awareness of infectious disease threats continues t%li%grow, the demand for advanced molecular diagnostic tests for infectious diseases in veterinary medicine is expected t%li%remain strong.
Regional Insights
North America emerged as the dominant region in the Global Veterinary Molecular Diagnostics Market in 2023, holding the largest market share. North America boasts a highly developed veterinary healthcare infrastructure, characterized by advanced diagnostic facilities, well-established veterinary clinics, and research institutions. The region benefits from a strong network of veterinary professionals, including veterinarians, laboratory technicians, and researchers, wh%li%are well-equipped t%li%adopt and utilize molecular diagnostic technologies in veterinary medicine effectively. Furthermore, North America is home t%li%several leading companies and research organizations at the forefront of innovation in veterinary molecular diagnostics. These companies invest heavily in research and development t%li%develop novel diagnostic assays, technologies, and platforms, driving market growth and competitiveness in the region. Favorable government policies, regulatory support, and reimbursement schemes for veterinary diagnostics contribute t%li%the market's growth trajectory in North America. The region's robust economy, high pet ownership rates, and increasing awareness of animal health and welfare als%li%fuel the demand for molecular diagnostic tests in veterinary medicine.
Key Market Players
In this report, the Global Veterinary Molecular Diagnostic Market has been segmented int%li%the following categories, in addition t%li%the industry trends which have als%li%been detailed below:
Company Profiles: Detailed analysis of the major companies present in the Global Veterinary Molecular Diagnostic Market.
Available Customizations:
Global Veterinary Molecular Diagnostic Market report with the given market data, TechSci Research offers customizations according t%li%a company's specific needs. The following customization options are available for the report:
Company Information
Furthermore, technological advancements such as point-of-care testing and the development of portable diagnostic devices are enhancing accessibility and efficiency in veterinary diagnostics, particularly in remote or resource-limited settings. The market is characterized by a competitive landscape with key players investing in research and development t%li%introduce innovative diagnostic solutions and broaden their product portfolios. Strategic collaborations, mergers, and acquisitions are prevalent strategies among market participants t%li%strengthen their market presence and expand their geographic reach. Regulatory initiatives aimed at standardizing veterinary diagnostics and ensuring product efficacy and safety are als%li%shaping the market landscape. As the global awareness of animal health and welfare continues t%li%rise, coupled with the increasing adoption of pets and livestock for companionship, food production, and other purposes, the veterinary molecular diagnostics market is anticipated t%li%witness sustained growth in the coming years.
Key Market Drivers
Rising Incidences of Infectious Diseases
The rising incidences of infectious diseases among animals have emerged as a significant driver fueling the growth of the Global Veterinary Molecular Diagnostics Market. Across the spectrum of animal populations, including pets, livestock, and wildlife, there has been a notable increase in the prevalence of infectious agents. Pathogens such as bacteria, viruses, fungi, and parasites pose substantial threats t%li%animal health, welfare, and productivity. Factors such as globalization, climate change, intensified livestock production systems, and changes in land use have contributed t%li%the spread and emergence of infectious diseases in animal populations.
Veterinary molecular diagnostics play a pivotal role in addressing this challenge by providing rapid and accurate identification of pathogens. Techniques such as Polymerase Chain Reaction (PCR), nucleic acid sequencing, and microarray analysis enable veterinarians t%li%detect and characterize infectious agents with high sensitivity and specificity. This capability is particularly crucial in the early diagnosis of emerging or novel pathogens for which traditional diagnostic methods may be inadequate or time-consuming. Furthermore, the ability t%li%swiftly identify infectious diseases facilitates prompt implementation of control measures, including quarantine, treatment, and vaccination programs. By containing outbreaks at their inception, molecular diagnostics help prevent the spread of diseases within animal populations and minimize their impact on animal health and productivity. Early detection enables veterinarians t%li%provide targeted treatment strategies, reducing the risk of antimicrobial resistance and improving treatment outcomes.
The demand for veterinary molecular diagnostics is further amplified by the economic consequences associated with infectious disease outbreaks. Disease outbreaks can result in significant losses for the livestock industry due t%li%decreased production, trade restrictions, and increased veterinary and healthcare costs. Timely and accurate diagnosis facilitated by molecular techniques helps mitigate these economic impacts by enabling swift intervention and control measures.
Technological Advancements
Technological advancements have been instrumental in propelling the growth of the Global Veterinary Molecular Diagnostics Market, revolutionizing the landscape of veterinary diagnostics and driving innovation in testing methodologies. These advancements have led t%li%the development of more sophisticated and efficient diagnostic tools, enabling veterinarians t%li%diagnose diseases with greater accuracy, speed, and convenience. One of the key technological advancements driving the veterinary molecular diagnostics market is the advent of Polymerase Chain Reaction (PCR) technology. PCR allows for the amplification of DNA or RNA sequences from a small sample, making it possible t%li%detect even trace amounts of pathogens in clinical specimens. This technique has become a cornerstone of veterinary diagnostics, enabling rapid and sensitive detection of infectious agents such as bacteria, viruses, and parasites.
In addition t%li%PCR, next-generation sequencing (NGS) technologies have revolutionized the field of molecular diagnostics by enabling high-throughput sequencing of entire genomes or targeted gene panels. NGS technologies offer unprecedented insights int%li%the genetic diversity of pathogens, facilitating the identification of emerging strains and the characterization of antimicrobial resistance genes. This information is invaluable for guiding treatment decisions and implementing effective control measures. Furthermore, microarray technology has emerged as a powerful tool for multiplexed detection of pathogens, allowing for the simultaneous analysis of multiple targets in a single assay. Microarrays offer high throughput and versatility, making them well-suited for screening large numbers of samples for infectious agents or genetic markers of disease.
The development of point-of-care testing (POCT) devices and portable diagnostic instruments has als%li%been a significant technological advancement in veterinary molecular diagnostics. These compact and user-friendly devices enable rapid on-site testing in diverse settings, including veterinary clinics, farms, and field research stations. POCT devices facilitate real-time decision-making and prompt initiation of treatment, improving patient outcomes and reducing the spread of infectious diseases.
Key Market Challenges
Cost Constraints
One of the primary challenges facing the Global Veterinary Molecular Diagnostics Market is the high cost associated with molecular diagnostic tests. The initial investment in equipment, reagents, and skilled personnel required t%li%perform molecular assays can be prohibitive for many veterinary clinics, particularly those in resource-limited settings or smaller practices. The cost of molecular tests themselves may be perceived as a barrier by pet owners or livestock producers, especially for routine screening or surveillance purposes. Addressing cost constraints through technological innovations, economies of scale, and strategic pricing strategies is essential t%li%enhance accessibility and affordability of molecular diagnostics in veterinary medicine.
Sample Quality and Handling
The quality of the sample plays a crucial role in the accuracy and reliability of molecular diagnostic tests. However, obtaining high-quality samples from animals can be challenging due t%li%various factors such as sample collection techniques, sample stability during transportation, and the presence of inhibitors that may interfere with molecular assays. Inadequate sample quality or improper handling procedures can lead t%li%false-negative or false-positive results, compromising the diagnostic accuracy of molecular tests. Addressing sample quality and handling challenges requires standardized protocols for sample collection, storage, and transportation, as well as the development of robust quality control measures t%li%assess sample integrity before testing.
Key Market Trends
Increasing Companion Animal Ownership
Increasing companion animal ownership has emerged as a significant driver fueling the growth of the Global Veterinary Molecular Diagnostics Market. The trend of pet ownership has been steadily rising worldwide, driven by factors such as urbanization, changing lifestyles, and growing awareness of the benefits of pet companionship. As more people welcome pets int%li%their homes, the demand for veterinary services, including diagnostic testing, has surged. Companion animals, including dogs, cats, and exotic pets, are valued members of the family, and pet owners are increasingly invested in ensuring their health and well-being. Molecular diagnostics play a crucial role in the diagnosis and management of various diseases and conditions in companion animals, offering greater accuracy, sensitivity, and efficiency compared t%li%traditional diagnostic methods.
One of the key drivers of demand for veterinary molecular diagnostics among pet owners is the desire for early disease detection and preventive care. Pet owners are proactive in seeking regular veterinary check-ups and screening tests for their pets t%li%identify potential health issues before they become symptomatic. Molecular diagnostic tests, such as PCR assays and genetic screening panels, enable veterinarians t%li%detect infectious diseases, genetic disorders, and predispositions t%li%certain conditions at earlier stages, allowing for timely intervention and treatment. The human-animal bond has strengthened in recent years, with pets playing increasingly integral roles in the lives of their owners. Pet owners are more willing t%li%invest in advanced veterinary care, including molecular diagnostics, t%li%ensure the health and longevity of their beloved companions. This emotional attachment t%li%pets drives demand for cutting-edge diagnostic technologies that offer greater diagnostic accuracy and treatment options.
Advancements in veterinary medicine, including personalized medicine and targeted therapies, have further fueled the demand for molecular diagnostics in companion animal healthcare. Molecular diagnostic tests provide valuable information about an individual animal's genetic makeup, enabling veterinarians t%li%tailor treatment plans t%li%the specific needs of each patient.
Focus on Food Safety and Animal Welfare
The focus on food safety and animal welfare has become increasingly prominent in recent years, driving the growth of the Global Veterinary Molecular Diagnostics Market. As consumers become more conscientious about the origin and quality of the food they consume, there is growing demand for rigorous safety standards and transparent supply chains in the food industry. In response, stakeholders across the food production chain, including producers, regulators, and consumers, are prioritizing measures t%li%ensure the safety and welfare of animals raised for food production. Veterinary molecular diagnostics play a critical role in enhancing food safety by enabling the rapid and accurate detection of pathogens in livestock and poultry populations. Infectious agents such as Salmonella, Campylobacter, and Escherichia coli pose significant risks t%li%human health if present in food products. Molecular diagnostic techniques, such as Polymerase Chain Reaction (PCR) and nucleic acid sequencing, offer high sensitivity and specificity in detecting these pathogens, allowing for timely intervention t%li%prevent foodborne illness outbreaks.
Furthermore, molecular diagnostics contribute t%li%animal welfare by facilitating early disease detection and monitoring in livestock populations. Diseases such as bovine respiratory disease, porcine reproductive and respiratory syndrome, and avian influenza can have detrimental effects on animal health and welfare, as well as on productivity in food animal production systems. By identifying infected animals and implementing appropriate control measures, molecular diagnostics help minimize the spread of diseases within herds and flocks, reducing suffering and improving overall welfare. The adoption of molecular diagnostics in veterinary medicine als%li%supports sustainable agricultural practices by promoting responsible antimicrobial use and reducing the need for prophylactic treatments. By accurately diagnosing diseases and identifying the causative agents, veterinarians can prescribe targeted therapies and interventions, minimizing the use of antibiotics and other antimicrobial agents. This approach helps mitigate the risk of antimicrobial resistance and supports the long-term viability of food production systems.
Segmental Insights
Product Insights
Based on the product, kit and reagents segment emerged as the dominant segment in the global Veterinary Molecular Diagnostic market in 2023. the kit and reagents segment benefits from the widespread adoption of molecular diagnostic techniques such as Polymerase Chain Reaction (PCR), which relies heavily on specific kits and reagents for amplification and detection of nucleic acids. These kits and reagents are essential components of molecular assays, enabling veterinarians t%li%perform a wide range of tests for the diagnosis of infectious diseases, genetic disorders, and other conditions in animals. Furthermore, advancements in kit and reagent technologies, such as the development of multiplex assays and ready-to-use PCR kits, have facilitated the adoption of molecular diagnostics in veterinary medicine. These innovations enhance the efficiency, accuracy, and convenience of testing procedures, further driving the growth of the kit and reagents segment.
Application Insights
Based on the application, infectious diseases segment emerged as the dominant segment in the global veterinary molecular diagnostic market in 2023. Infectious diseases pose significant threats t%li%animal health, welfare, and productivity, making their accurate and timely diagnosis a top priority for veterinarians and livestock producers. Molecular diagnostic techniques offer unparalleled sensitivity and specificity in detecting a wide range of pathogens, including bacteria, viruses, fungi, and parasites, facilitating rapid identification and control of infectious disease outbreaks. As the global awareness of infectious disease threats continues t%li%grow, the demand for advanced molecular diagnostic tests for infectious diseases in veterinary medicine is expected t%li%remain strong.
Regional Insights
North America emerged as the dominant region in the Global Veterinary Molecular Diagnostics Market in 2023, holding the largest market share. North America boasts a highly developed veterinary healthcare infrastructure, characterized by advanced diagnostic facilities, well-established veterinary clinics, and research institutions. The region benefits from a strong network of veterinary professionals, including veterinarians, laboratory technicians, and researchers, wh%li%are well-equipped t%li%adopt and utilize molecular diagnostic technologies in veterinary medicine effectively. Furthermore, North America is home t%li%several leading companies and research organizations at the forefront of innovation in veterinary molecular diagnostics. These companies invest heavily in research and development t%li%develop novel diagnostic assays, technologies, and platforms, driving market growth and competitiveness in the region. Favorable government policies, regulatory support, and reimbursement schemes for veterinary diagnostics contribute t%li%the market's growth trajectory in North America. The region's robust economy, high pet ownership rates, and increasing awareness of animal health and welfare als%li%fuel the demand for molecular diagnostic tests in veterinary medicine.
Key Market Players
- Biochek BV
- Biomerieux SA
- Bioneer Corporation
- Idexx Laboratories Inc.
- Ingenetix GmbH
- Neogen Corporation
- Therm%li%Fischer Scientific Inc.
- Veterinary Molecular Diagnostics Inc.
- Biomedica Medizinprodukte GmbH
- Novacyt Group
In this report, the Global Veterinary Molecular Diagnostic Market has been segmented int%li%the following categories, in addition t%li%the industry trends which have als%li%been detailed below:
- Veterinary Molecular Diagnostic Market, By Product:
- Instruments
- Kit and Reagents
- Software and Services
- Veterinary Molecular Diagnostic Market, By Application:
- Infectious Diseases
- Genetics
- Other
- Veterinary Molecular Diagnostic Market, By Technology:
- PCR
- Microarray
- DNA Sequencing
- Veterinary Molecular Diagnostic Market, By Region:
- North America
- United States
- Canada
- Mexico
- Europe
- France
- United Kingdom
- Italy
- Germany
- Spain
- Asia-Pacific
- China
- India
- Japan
- Australia
- South Korea
- South America
- Brazil
- Argentina
- Colombia
- Middle East & Africa
- South Africa
- Saudi Arabia
- UAE
Company Profiles: Detailed analysis of the major companies present in the Global Veterinary Molecular Diagnostic Market.
Available Customizations:
Global Veterinary Molecular Diagnostic Market report with the given market data, TechSci Research offers customizations according t%li%a company's specific needs. The following customization options are available for the report:
Company Information
- Detailed analysis and profiling of additional market players (up t%li%five).
1. PRODUCT OVERVIEW
1.1. Market Definition
1.2. Scope of the Market
1.2.1. Markets Covered
1.2.2. Years Considered for Study
1.2.3. Key Market Segmentations
2. RESEARCH METHODOLOGY
2.1. Objective of the Study
2.2. Baseline Methodology
2.3. Key Industry Partners
2.4. Major Association and Secondary Sources
2.5. Forecasting Methodology
2.6. Data Triangulation & Validation
2.7. Assumptions and Limitations
3. EXECUTIVE SUMMARY
3.1. Overview of the Market
3.2. Overview of Key Market Segmentations
3.3. Overview of Key Market Players
3.4. Overview of Key Regions/Countries
3.5. Overview of Market Drivers, Challenges, and Trends
4. VOICE OF CUSTOMER
5. GLOBAL VETERINARY MOLECULAR DIAGNOSTICS MARKET OUTLOOK
5.1. Market Size & Forecast
5.1.1. By Value
5.2. Market Share & Forecast
5.2.1. By Product (Instruments, Kit and Reagents, Software and Services)
5.2.2. By Application (Infectious Diseases, Genetics, Other)
5.2.3. By Technology (PCR, Microarray, DNA Sequencing)
5.2.4. By Company (2023)
5.2.5. By Region
5.3. Market Map
6. NORTH AMERICA VETERINARY MOLECULAR DIAGNOSTICS MARKET OUTLOOK
6.1. Market Size & Forecast
6.1.1. By Value
6.2. Market Share & Forecast
6.2.1. By Product
6.2.2. By Application
6.2.3. By Technology
6.2.4. By Country
6.3. North America: Country Analysis
6.3.1. United States Veterinary Molecular Diagnostics Market Outlook
6.3.1.1. Market Size & Forecast
6.3.1.1.1. By Value
6.3.1.2. Market Share & Forecast
6.3.1.2.1. By Product
6.3.1.2.2. By Application
6.3.1.2.3. By Technology
6.3.2. Mexico Veterinary Molecular Diagnostics Market Outlook
6.3.2.1. Market Size & Forecast
6.3.2.1.1. By Value
6.3.2.2. Market Share & Forecast
6.3.2.2.1. By Product
6.3.2.2.2. By Application
6.3.2.2.3. By Technology
6.3.3. Canada Veterinary Molecular Diagnostics Market Outlook
6.3.3.1. Market Size & Forecast
6.3.3.1.1. By Value
6.3.3.2. Market Share & Forecast
6.3.3.2.1. By Product
6.3.3.2.2. By Application
6.3.3.2.3. By Technology
7. EUROPE VETERINARY MOLECULAR DIAGNOSTICS MARKET OUTLOOK
7.1. Market Size & Forecast
7.1.1. By Value
7.2. Market Share & Forecast
7.2.1. By Product
7.2.2. By Application
7.2.3. By Technology
7.2.4. By Country
7.3. Europe: Country Analysis
7.3.1. France Veterinary Molecular Diagnostics Market Outlook
7.3.1.1. Market Size & Forecast
7.3.1.1.1. By Value
7.3.1.2. Market Share & Forecast
7.3.1.2.1. By Product
7.3.1.2.2. By Application
7.3.1.2.3. By Technology
7.3.2. Germany Veterinary Molecular Diagnostics Market Outlook
7.3.2.1. Market Size & Forecast
7.3.2.1.1. By Value
7.3.2.2. Market Share & Forecast
7.3.2.2.1. By Product
7.3.2.2.2. By Application
7.3.2.2.3. By Technology
7.3.3. United Kingdom Veterinary Molecular Diagnostics Market Outlook
7.3.3.1. Market Size & Forecast
7.3.3.1.1. By Value
7.3.3.2. Market Share & Forecast
7.3.3.2.1. By Product
7.3.3.2.2. By Application
7.3.3.2.3. By Technology
7.3.4. Italy Veterinary Molecular Diagnostics Market Outlook
7.3.4.1. Market Size & Forecast
7.3.4.1.1. By Value
7.3.4.2. Market Share & Forecast
7.3.4.2.1. By Product
7.3.4.2.2. By Application
7.3.4.2.3. By Technology
7.3.5. Spain Veterinary Molecular Diagnostics Market Outlook
7.3.5.1. Market Size & Forecast
7.3.5.1.1. By Value
7.3.5.2. Market Share & Forecast
7.3.5.2.1. By Product
7.3.5.2.2. By Application
7.3.5.2.3. By Technology
8. ASIA-PACIFIC VETERINARY MOLECULAR DIAGNOSTICS MARKET OUTLOOK
8.1. Market Size & Forecast
8.1.1. By Value
8.2. Market Share & Forecast
8.2.1. By Product
8.2.2. By Application
8.2.3. By Technology
8.2.4. By Country
8.3. Asia-Pacific: Country Analysis
8.3.1. China Veterinary Molecular Diagnostics Market Outlook
8.3.1.1. Market Size & Forecast
8.3.1.1.1. By Value
8.3.1.2. Market Share & Forecast
8.3.1.2.1. By Product
8.3.1.2.2. By Application
8.3.1.2.3. By Technology
8.3.2. India Veterinary Molecular Diagnostics Market Outlook
8.3.2.1. Market Size & Forecast
8.3.2.1.1. By Value
8.3.2.2. Market Share & Forecast
8.3.2.2.1. By Product
8.3.2.2.2. By Application
8.3.2.2.3. By Technology
8.3.3. South Korea Veterinary Molecular Diagnostics Market Outlook
8.3.3.1. Market Size & Forecast
8.3.3.1.1. By Value
8.3.3.2. Market Share & Forecast
8.3.3.2.1. By Product
8.3.3.2.2. By Application
8.3.3.2.3. By Technology
8.3.4. Japan Veterinary Molecular Diagnostics Market Outlook
8.3.4.1. Market Size & Forecast
8.3.4.1.1. By Value
8.3.4.2. Market Share & Forecast
8.3.4.2.1. By Product
8.3.4.2.2. By Application
8.3.4.2.3. By Technology
8.3.5. Australia Veterinary Molecular Diagnostics Market Outlook
8.3.5.1. Market Size & Forecast
8.3.5.1.1. By Value
8.3.5.2. Market Share & Forecast
8.3.5.2.1. By Product
8.3.5.2.2. By Application
8.3.5.2.3. By Technology
9. SOUTH AMERICA VETERINARY MOLECULAR DIAGNOSTICS MARKET OUTLOOK
9.1. Market Size & Forecast
9.1.1. By Value
9.2. Market Share & Forecast
9.2.1. By Product
9.2.2. By Application
9.2.3. By Technology
9.2.4. By Country
9.3. South America: Country Analysis
9.3.1. Brazil Veterinary Molecular Diagnostics Market Outlook
9.3.1.1. Market Size & Forecast
9.3.1.1.1. By Value
9.3.1.2. Market Share & Forecast
9.3.1.2.1. By Product
9.3.1.2.2. By Application
9.3.1.2.3. By Technology
9.3.2. Argentina Veterinary Molecular Diagnostics Market Outlook
9.3.2.1. Market Size & Forecast
9.3.2.1.1. By Value
9.3.2.2. Market Share & Forecast
9.3.2.2.1. By Product
9.3.2.2.2. By Application
9.3.2.2.3. By Technology
9.3.3. Colombia Veterinary Molecular Diagnostics Market Outlook
9.3.3.1. Market Size & Forecast
9.3.3.1.1. By Value
9.3.3.2. Market Share & Forecast
9.3.3.2.1. By Product
9.3.3.2.2. By Application
9.3.3.2.3. By Technology
10. MIDDLE EAST AND AFRICA VETERINARY MOLECULAR DIAGNOSTICS MARKET OUTLOOK
10.1. Market Size & Forecast
10.1.1. By Value
10.2. Market Share & Forecast
10.2.1. By Product
10.2.2. By Application
10.2.3. By Technology
10.2.4. By Country
10.3. MEA: Country Analysis
10.3.1. South Africa Veterinary Molecular Diagnostics Market Outlook
10.3.1.1. Market Size & Forecast
10.3.1.1.1. By Value
10.3.1.2. Market Share & Forecast
10.3.1.2.1. By Product
10.3.1.2.2. By Application
10.3.1.2.3. By Technology
10.3.2. Saudi Arabia Veterinary Molecular Diagnostics Market Outlook
10.3.2.1. Market Size & Forecast
10.3.2.1.1. By Value
10.3.2.2. Market Share & Forecast
10.3.2.2.1. By Product
10.3.2.2.2. By Application
10.3.2.2.3. By Technology
10.3.3. UAE Veterinary Molecular Diagnostics Market Outlook
10.3.3.1. Market Size & Forecast
10.3.3.1.1. By Value
10.3.3.2. Market Share & Forecast
10.3.3.2.1. By Product
10.3.3.2.2. By Application
10.3.3.2.3. By Technology
11. MARKET DYNAMICS
11.1. Drivers
11.2. Challenges
12. MARKET TRENDS & DEVELOPMENTS
12.1. Merger & Acquisition (If Any)
12.2. Product Launches (If Any)
12.3. Recent Developments
13. PORTERS FIVE FORCES ANALYSIS
13.1. Competition in the Industry
13.2. Potential of New Entrants
13.3. Power of Suppliers
13.4. Power of Customers
13.5. Threat of Substitute Products
14. COMPETITIVE LANDSCAPE
14.1. Biochek BV
14.1.1. Business Overview
14.1.2. Company Snapshot
14.1.3. Products & Services
14.1.4. Financials (As Reported)
14.1.5. Recent Developments
14.1.6. Key Personnel Details
14.1.7. SWOT Analysis
14.2. Biomerieux SA
14.3. Bioneer Corporation
14.4. Idexx Laboratories Inc.
14.5. Ingenetix GmbH
14.6. Neogen Corporation
14.7. Thermo Fischer Scientific Inc.
14.8. Veterinary Molecular Diagnostics Inc.
14.9. Biomedica Medizinprodukte GmbH
14.10. Novacyt Group
15. STRATEGIC RECOMMENDATIONS
16. ABOUT US & DISCLAIMER
1.1. Market Definition
1.2. Scope of the Market
1.2.1. Markets Covered
1.2.2. Years Considered for Study
1.2.3. Key Market Segmentations
2. RESEARCH METHODOLOGY
2.1. Objective of the Study
2.2. Baseline Methodology
2.3. Key Industry Partners
2.4. Major Association and Secondary Sources
2.5. Forecasting Methodology
2.6. Data Triangulation & Validation
2.7. Assumptions and Limitations
3. EXECUTIVE SUMMARY
3.1. Overview of the Market
3.2. Overview of Key Market Segmentations
3.3. Overview of Key Market Players
3.4. Overview of Key Regions/Countries
3.5. Overview of Market Drivers, Challenges, and Trends
4. VOICE OF CUSTOMER
5. GLOBAL VETERINARY MOLECULAR DIAGNOSTICS MARKET OUTLOOK
5.1. Market Size & Forecast
5.1.1. By Value
5.2. Market Share & Forecast
5.2.1. By Product (Instruments, Kit and Reagents, Software and Services)
5.2.2. By Application (Infectious Diseases, Genetics, Other)
5.2.3. By Technology (PCR, Microarray, DNA Sequencing)
5.2.4. By Company (2023)
5.2.5. By Region
5.3. Market Map
6. NORTH AMERICA VETERINARY MOLECULAR DIAGNOSTICS MARKET OUTLOOK
6.1. Market Size & Forecast
6.1.1. By Value
6.2. Market Share & Forecast
6.2.1. By Product
6.2.2. By Application
6.2.3. By Technology
6.2.4. By Country
6.3. North America: Country Analysis
6.3.1. United States Veterinary Molecular Diagnostics Market Outlook
6.3.1.1. Market Size & Forecast
6.3.1.1.1. By Value
6.3.1.2. Market Share & Forecast
6.3.1.2.1. By Product
6.3.1.2.2. By Application
6.3.1.2.3. By Technology
6.3.2. Mexico Veterinary Molecular Diagnostics Market Outlook
6.3.2.1. Market Size & Forecast
6.3.2.1.1. By Value
6.3.2.2. Market Share & Forecast
6.3.2.2.1. By Product
6.3.2.2.2. By Application
6.3.2.2.3. By Technology
6.3.3. Canada Veterinary Molecular Diagnostics Market Outlook
6.3.3.1. Market Size & Forecast
6.3.3.1.1. By Value
6.3.3.2. Market Share & Forecast
6.3.3.2.1. By Product
6.3.3.2.2. By Application
6.3.3.2.3. By Technology
7. EUROPE VETERINARY MOLECULAR DIAGNOSTICS MARKET OUTLOOK
7.1. Market Size & Forecast
7.1.1. By Value
7.2. Market Share & Forecast
7.2.1. By Product
7.2.2. By Application
7.2.3. By Technology
7.2.4. By Country
7.3. Europe: Country Analysis
7.3.1. France Veterinary Molecular Diagnostics Market Outlook
7.3.1.1. Market Size & Forecast
7.3.1.1.1. By Value
7.3.1.2. Market Share & Forecast
7.3.1.2.1. By Product
7.3.1.2.2. By Application
7.3.1.2.3. By Technology
7.3.2. Germany Veterinary Molecular Diagnostics Market Outlook
7.3.2.1. Market Size & Forecast
7.3.2.1.1. By Value
7.3.2.2. Market Share & Forecast
7.3.2.2.1. By Product
7.3.2.2.2. By Application
7.3.2.2.3. By Technology
7.3.3. United Kingdom Veterinary Molecular Diagnostics Market Outlook
7.3.3.1. Market Size & Forecast
7.3.3.1.1. By Value
7.3.3.2. Market Share & Forecast
7.3.3.2.1. By Product
7.3.3.2.2. By Application
7.3.3.2.3. By Technology
7.3.4. Italy Veterinary Molecular Diagnostics Market Outlook
7.3.4.1. Market Size & Forecast
7.3.4.1.1. By Value
7.3.4.2. Market Share & Forecast
7.3.4.2.1. By Product
7.3.4.2.2. By Application
7.3.4.2.3. By Technology
7.3.5. Spain Veterinary Molecular Diagnostics Market Outlook
7.3.5.1. Market Size & Forecast
7.3.5.1.1. By Value
7.3.5.2. Market Share & Forecast
7.3.5.2.1. By Product
7.3.5.2.2. By Application
7.3.5.2.3. By Technology
8. ASIA-PACIFIC VETERINARY MOLECULAR DIAGNOSTICS MARKET OUTLOOK
8.1. Market Size & Forecast
8.1.1. By Value
8.2. Market Share & Forecast
8.2.1. By Product
8.2.2. By Application
8.2.3. By Technology
8.2.4. By Country
8.3. Asia-Pacific: Country Analysis
8.3.1. China Veterinary Molecular Diagnostics Market Outlook
8.3.1.1. Market Size & Forecast
8.3.1.1.1. By Value
8.3.1.2. Market Share & Forecast
8.3.1.2.1. By Product
8.3.1.2.2. By Application
8.3.1.2.3. By Technology
8.3.2. India Veterinary Molecular Diagnostics Market Outlook
8.3.2.1. Market Size & Forecast
8.3.2.1.1. By Value
8.3.2.2. Market Share & Forecast
8.3.2.2.1. By Product
8.3.2.2.2. By Application
8.3.2.2.3. By Technology
8.3.3. South Korea Veterinary Molecular Diagnostics Market Outlook
8.3.3.1. Market Size & Forecast
8.3.3.1.1. By Value
8.3.3.2. Market Share & Forecast
8.3.3.2.1. By Product
8.3.3.2.2. By Application
8.3.3.2.3. By Technology
8.3.4. Japan Veterinary Molecular Diagnostics Market Outlook
8.3.4.1. Market Size & Forecast
8.3.4.1.1. By Value
8.3.4.2. Market Share & Forecast
8.3.4.2.1. By Product
8.3.4.2.2. By Application
8.3.4.2.3. By Technology
8.3.5. Australia Veterinary Molecular Diagnostics Market Outlook
8.3.5.1. Market Size & Forecast
8.3.5.1.1. By Value
8.3.5.2. Market Share & Forecast
8.3.5.2.1. By Product
8.3.5.2.2. By Application
8.3.5.2.3. By Technology
9. SOUTH AMERICA VETERINARY MOLECULAR DIAGNOSTICS MARKET OUTLOOK
9.1. Market Size & Forecast
9.1.1. By Value
9.2. Market Share & Forecast
9.2.1. By Product
9.2.2. By Application
9.2.3. By Technology
9.2.4. By Country
9.3. South America: Country Analysis
9.3.1. Brazil Veterinary Molecular Diagnostics Market Outlook
9.3.1.1. Market Size & Forecast
9.3.1.1.1. By Value
9.3.1.2. Market Share & Forecast
9.3.1.2.1. By Product
9.3.1.2.2. By Application
9.3.1.2.3. By Technology
9.3.2. Argentina Veterinary Molecular Diagnostics Market Outlook
9.3.2.1. Market Size & Forecast
9.3.2.1.1. By Value
9.3.2.2. Market Share & Forecast
9.3.2.2.1. By Product
9.3.2.2.2. By Application
9.3.2.2.3. By Technology
9.3.3. Colombia Veterinary Molecular Diagnostics Market Outlook
9.3.3.1. Market Size & Forecast
9.3.3.1.1. By Value
9.3.3.2. Market Share & Forecast
9.3.3.2.1. By Product
9.3.3.2.2. By Application
9.3.3.2.3. By Technology
10. MIDDLE EAST AND AFRICA VETERINARY MOLECULAR DIAGNOSTICS MARKET OUTLOOK
10.1. Market Size & Forecast
10.1.1. By Value
10.2. Market Share & Forecast
10.2.1. By Product
10.2.2. By Application
10.2.3. By Technology
10.2.4. By Country
10.3. MEA: Country Analysis
10.3.1. South Africa Veterinary Molecular Diagnostics Market Outlook
10.3.1.1. Market Size & Forecast
10.3.1.1.1. By Value
10.3.1.2. Market Share & Forecast
10.3.1.2.1. By Product
10.3.1.2.2. By Application
10.3.1.2.3. By Technology
10.3.2. Saudi Arabia Veterinary Molecular Diagnostics Market Outlook
10.3.2.1. Market Size & Forecast
10.3.2.1.1. By Value
10.3.2.2. Market Share & Forecast
10.3.2.2.1. By Product
10.3.2.2.2. By Application
10.3.2.2.3. By Technology
10.3.3. UAE Veterinary Molecular Diagnostics Market Outlook
10.3.3.1. Market Size & Forecast
10.3.3.1.1. By Value
10.3.3.2. Market Share & Forecast
10.3.3.2.1. By Product
10.3.3.2.2. By Application
10.3.3.2.3. By Technology
11. MARKET DYNAMICS
11.1. Drivers
11.2. Challenges
12. MARKET TRENDS & DEVELOPMENTS
12.1. Merger & Acquisition (If Any)
12.2. Product Launches (If Any)
12.3. Recent Developments
13. PORTERS FIVE FORCES ANALYSIS
13.1. Competition in the Industry
13.2. Potential of New Entrants
13.3. Power of Suppliers
13.4. Power of Customers
13.5. Threat of Substitute Products
14. COMPETITIVE LANDSCAPE
14.1. Biochek BV
14.1.1. Business Overview
14.1.2. Company Snapshot
14.1.3. Products & Services
14.1.4. Financials (As Reported)
14.1.5. Recent Developments
14.1.6. Key Personnel Details
14.1.7. SWOT Analysis
14.2. Biomerieux SA
14.3. Bioneer Corporation
14.4. Idexx Laboratories Inc.
14.5. Ingenetix GmbH
14.6. Neogen Corporation
14.7. Thermo Fischer Scientific Inc.
14.8. Veterinary Molecular Diagnostics Inc.
14.9. Biomedica Medizinprodukte GmbH
14.10. Novacyt Group
15. STRATEGIC RECOMMENDATIONS
16. ABOUT US & DISCLAIMER
